See also this year's filing and all EDGAR filings for this company.
PDF Report 0001017491_2024_Seelos_Therapeutics_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001017491, Seelos Therapeutics INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 5,403,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 15,000 |
| 4 | LiabilitiesCurrent | 38,928,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 12,626,389 |
| 9 | ResearchAndDevelopmentExpense | 36,158,673 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 1,429,977 |
| 12 | remainder_NetIncome | 1,356,239 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 5,418,000 |
| 1 | Liabilities | 38,928,000 |
| 2 | Expenses | 48,785,062 |
| 3 | Revenues | 1,429,977 |
| 4 | StockholdersEquity | -33,510,000 |
| 5 | NetIncome | -45,998,846 |
| 6 | ComprehensiveNetIncome | -45,998,846 |
| 7 | BaseVar | 47,958,639 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -5.37 |
| 9 | EconomicCapitalRatio | 0.141 |